A widely employed germ cell marker is an ancient disordered protein with reproductive functions in diverse eukaryotes

  1. Michelle A Carmell  Is a corresponding author
  2. Gregoriy A Dokshin
  3. Helen Skaletsky
  4. Yueh-Chiang Hu
  5. Josien C van Wolfswinkel
  6. Kyomi J Igarashi
  7. Daniel W Bellott
  8. Michael Nefedov
  9. Peter W Reddien
  10. George C Enders
  11. Vladimir N Uversky
  12. Craig C Mello
  13. David C Page  Is a corresponding author
  1. Whitehead Institute, United States
  2. University of Massachusetts Medical School, United States
  3. Cincinnati Children's Hospital Medical Center, United States
  4. Yale University, United States
  5. University of Queensland, United States
  6. University of Kansas Medical Center, United States
  7. University of South Florida, United States

Abstract

The advent of sexual reproduction and the evolution of a dedicated germline in multicellular organisms are critical landmarks in eukaryotic evolution. We report an ancient family of GCNA (germ cell nuclear antigen) proteins that arose in the earliest eukaryotes, and feature a rapidly evolving intrinsically disordered region (IDR). Phylogenetic analysis reveals that GCNA proteins emerged before the major eukaryotic lineages diverged; GCNA predates the origin of a dedicated germline by a billion years. Gcna gene expression is enriched in reproductive cells across eukarya - either just prior to or during meiosis in single-celled eukaryotes, and in stem cells and germ cells of diverse multicellular animals. Studies of Gcna-mutant C. elegans and mice indicate that GCNA has functioned in reproduction for at least 600 million years. Homology to IDR-containing proteins implicated in DNA damage repair suggests that GCNA proteins may protect the genomic integrity of cells carrying a heritable genome.

Article and author information

Author details

  1. Michelle A Carmell

    Whitehead Institute, Cambridge, United States
    For correspondence
    carmell@wi.mit.edu
    Competing interests
    The authors declare that no competing interests exist.
  2. Gregoriy A Dokshin

    RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Helen Skaletsky

    Whitehead Institute, Cambridge, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Yueh-Chiang Hu

    Division of Developmental Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Josien C van Wolfswinkel

    MCDB, Yale University, New Haven, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4221-3218
  6. Kyomi J Igarashi

    Whitehead Institute, Cambridge, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. Daniel W Bellott

    Whitehead Institute, Cambridge, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. Michael Nefedov

    School of Chemistry and Molecular Biosciences, University of Queensland, Brisbane, United States
    Competing interests
    The authors declare that no competing interests exist.
  9. Peter W Reddien

    Whitehead Institute, Cambridge, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5569-333X
  10. George C Enders

    Department of Anatomy and Cell Biology, University of Kansas Medical Center, Kansas City, United States
    Competing interests
    The authors declare that no competing interests exist.
  11. Vladimir N Uversky

    Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, Tampa, United States
    Competing interests
    The authors declare that no competing interests exist.
  12. Craig C Mello

    RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, United States
    Competing interests
    The authors declare that no competing interests exist.
  13. David C Page

    Whitehead Institute, Cambridge, United States
    For correspondence
    dcpage@wi.mit.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-9920-3411

Funding

Howard Hughes Medical Institute

  • Michelle A Carmell
  • Gregoriy A Dokshin
  • Helen Skaletsky
  • Yueh-Chiang Hu
  • Kyomi J Igarashi
  • Daniel W Bellott
  • Peter W Reddien
  • Craig C Mello

Life Sciences Research Foundation

  • Michelle A Carmell

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: All mouse studies were performed using a protocol approved by the Committee on Animal Care at the Massachusetts Institute of Technology (Protocol number: 0714-074-17).

Copyright

© 2016, Carmell et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 4,896
    views
  • 1,084
    downloads
  • 61
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Michelle A Carmell
  2. Gregoriy A Dokshin
  3. Helen Skaletsky
  4. Yueh-Chiang Hu
  5. Josien C van Wolfswinkel
  6. Kyomi J Igarashi
  7. Daniel W Bellott
  8. Michael Nefedov
  9. Peter W Reddien
  10. George C Enders
  11. Vladimir N Uversky
  12. Craig C Mello
  13. David C Page
(2016)
A widely employed germ cell marker is an ancient disordered protein with reproductive functions in diverse eukaryotes
eLife 5:e19993.
https://doi.org/10.7554/eLife.19993

Share this article

https://doi.org/10.7554/eLife.19993

Further reading

    1. Developmental Biology
    Hanee Lee, Junsu Kang ... Junho Lee
    Research Article

    The evolutionarily conserved Hippo (Hpo) pathway has been shown to impact early development and tumorigenesis by governing cell proliferation and apoptosis. However, its post-developmental roles are relatively unexplored. Here, we demonstrate its roles in post-mitotic cells by showing that defective Hpo signaling accelerates age-associated structural and functional decline of neurons in Caenorhabditis elegans. Loss of wts-1/LATS, the core kinase of the Hpo pathway, resulted in premature deformation of touch neurons and impaired touch responses in a yap-1/YAP-dependent manner, the downstream transcriptional co-activator of LATS. Decreased movement as well as microtubule destabilization by treatment with colchicine or disruption of microtubule-stabilizing genes alleviated the neuronal deformation of wts-1 mutants. Colchicine exerted neuroprotective effects even during normal aging. In addition, the deficiency of a microtubule-severing enzyme spas-1 also led to precocious structural deformation. These results consistently suggest that hyper-stabilized microtubules in both wts-1-deficient neurons and normally aged neurons are detrimental to the maintenance of neuronal structural integrity. In summary, Hpo pathway governs the structural and functional maintenance of differentiated neurons by modulating microtubule stability, raising the possibility that the microtubule stability of fully developed neurons could be a promising target to delay neuronal aging. Our study provides potential therapeutic approaches to combat age- or disease-related neurodegeneration.

    1. Developmental Biology
    Bin Zhu, Rui Wei ... Pei Liang
    Research Article

    Wing dimorphism is a common phenomenon that plays key roles in the environmental adaptation of aphid; however, the signal transduction in response to environmental cues and the regulation mechanism related to this event remain unknown. Adenosine (A) to inosine (I) RNA editing is a post-transcriptional modification that extends transcriptome variety without altering the genome, playing essential roles in numerous biological and physiological processes. Here, we present a chromosome-level genome assembly of the rose-grain aphid Metopolophium dirhodum by using PacBio long HiFi reads and Hi-C technology. The final genome assembly for M. dirhodum is 447.8 Mb, with 98.50% of the assembled sequences anchored to nine chromosomes. The contig and scaffold N50 values are 7.82 and 37.54 Mb, respectively. A total of 18,003 protein-coding genes were predicted, of which 92.05% were functionally annotated. In addition, 11,678 A-to-I RNA-editing sites were systematically identified based on this assembled M. dirhodum genome, and two synonymous A-to-I RNA-editing sites on CYP18A1 were closely associated with transgenerational wing dimorphism induced by crowding. One of these A-to-I RNA-editing sites may prevent the binding of miR-3036-5p to CYP18A1, thus elevating CYP18A1 expression, decreasing 20E titer, and finally regulating the wing dimorphism of offspring. Meanwhile, crowding can also inhibit miR-3036-5p expression and further increase CYP18A1 abundance, resulting in winged offspring. These findings support that A-to-I RNA editing is a dynamic mechanism in the regulation of transgenerational wing dimorphism in aphids and would advance our understanding of the roles of RNA editing in environmental adaptability and phenotypic plasticity.